Jupiter Neurosciences Inc
JUNS1.450USD
+0.090+6.62%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
48.00MMarket Cap
LossP/E TTM
Jupiter Neurosciences Inc
1.450
+0.090+6.62%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2022Q4
FY2022Q3
FY2021Q4
FY2021Q3
FY2020Q4
FY2020Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-1531.31%-1.06M
-2193.56%-3.70M
73.89%-42.60K
---107.46K
---65.17K
17.00%-161.14K
52.00%-163.18K
83.03%-194.14K
38.29%-339.97K
-822.22%-1.14M
-89.16%-550.94K
--158.44K
---291.25K
Net income from continuing operations
-141.11%-1.53M
-255.56%-1.53M
66.69%-591.02K
--313.12K
---634.10K
75.42%-429.64K
-13.82%-1.77M
8.32%-1.75M
-31.00%-1.56M
-310.56%-1.91M
-143.85%-1.19M
---464.37K
---487.95K
Other non-cash items
639.90%189.04K
3411.84%177.03K
-97.73%5.04K
---946.88K
---35.01K
-99.51%5.04K
-4.93%222.46K
331.97%1.04M
1740.06%233.99K
--239.85K
-119.21%-14.27K
--0.00
--74.26K
Change in working capital
-168.59%-144.67K
-1666.04%-3.36M
-67.48%358.21K
--223.88K
--210.92K
-55.86%214.47K
105.65%1.10M
1612.45%485.84K
114.57%535.60K
-94.44%28.37K
17.42%249.61K
--509.85K
--212.58K
-Change in receivables
----
---2.30M
----
----
----
----
----
----
----
100.00%0.00
100.00%0.00
---25.23K
---101.00K
-Change in prepaid expenses
---24.11K
----
----
----
--0.00
----
----
----
----
----
----
----
----
-Change in payables and accrued expense
-959.92%-113.55K
-583.82%-267.08K
12.84%83.03K
--21.32K
--13.21K
90.68%-39.06K
-71.81%73.58K
-193.44%-419.30K
104.74%261.00K
132.36%448.72K
460.90%127.47K
--193.12K
--22.73K
-Change in other current assets
-231.16%-659.00
-80049.43%-139.46K
1576.36%24.39K
---343.00
---199.00
-101.80%-174.00
-85.35%1.46K
116.39%9.68K
-40.22%9.94K
-341.49%-59.06K
13.12%16.62K
--24.46K
--14.69K
Cash from non-recurring investing activities
Cash from operating activities
-1531.31%-1.06M
-2193.56%-3.70M
73.89%-42.60K
---107.46K
---65.17K
17.00%-161.14K
52.00%-163.18K
83.03%-194.14K
38.29%-339.97K
-822.22%-1.14M
-89.16%-550.94K
--158.44K
---291.25K
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
----
5642.34%7.47M
-85.64%28.00K
--114.00K
--45.00K
--130.00K
--195.00K
-100.00%0.00
-100.00%0.00
--287.50K
1079.57%1.00M
--0.00
--85.00K
Net cash flow from debt Issuance/repayment
----
-1915.52%-2.36M
-85.64%28.00K
--64.00K
--45.00K
--130.00K
--195.00K
-100.00%0.00
-100.00%0.00
--100.00K
278.19%427.65K
--0.00
---240.00K
Net cash flow from common stock issuance/repurchase
----
--9.83M
--0.00
--50.00K
----
--0.00
--0.00
--0.00
----
----
-253.85%-500.00K
--0.00
--325.00K
Proceeds from stock option exercised by employees
----
----
----
----
----
----
----
----
----
--187.50K
--575.00K
--0.00
--0.00
Net cash flow from other financing activities
----
---2.21M
----
----
----
----
----
----
----
--0.00
--500.00K
--0.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
----
5642.34%7.47M
-85.64%28.00K
--114.00K
--45.00K
--130.00K
--195.00K
-100.00%0.00
-100.00%0.00
--287.50K
1079.57%1.00M
--0.00
--85.00K
Net cash flow
Beginning cash balance
13136.57%3.77M
-99.58%253.00
-46.56%14.85K
--8.31K
--28.48K
-76.94%59.62K
-95.36%27.79K
-78.22%258.57K
-18.64%598.54K
2296.15%1.19M
187.60%735.70K
--49.55K
--255.81K
Current period cash flow changes
-5171.71%-1.06M
12205.40%3.77M
-145.87%-14.60K
--6.54K
---20.16K
83.96%-31.14K
109.36%31.82K
77.34%-194.14K
-175.26%-339.97K
-640.77%-856.81K
319.01%451.71K
--158.44K
---206.25K
Ending cash balance
32457.07%2.71M
13136.57%3.77M
-99.58%253.00
--14.85K
--8.31K
-55.80%28.48K
-76.94%59.62K
-80.51%64.43K
-78.22%258.57K
58.94%330.60K
2296.15%1.19M
--208.00K
--49.55K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
